← All Io Biotech, INC filings

Io Biotech, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

IOBT
Io Biotech, INC
10-K: IO Biotech's 10-K Filing Reveals Phase 3 Trial Update and Pipeline Progress
IO Biotech's 10-K filing highlights the company's progress in clinical trials, particularly the Phase 3 trial for Cylembio, and its ongoing development of novel cancer vaccines.
IOBT
Io Biotech, INC
10-K/A: IO Biotech Files Amended 10-K to Correct Signature Omission
IO Biotech filed an amendment to its annual report to include the missing signature of the Principal Accounting Officer, with no changes to the financial statements or other disclosures.
IOBT
Io Biotech, INC
10-K: IO Biotech Details Capital Stock Structure and Regulatory Compliance in 10-K Filing
IO Biotech's 10-K filing provides a detailed overview of its capital stock, governance, and regulatory compliance, highlighting key aspects for investors.